JENNISON ASSOCIATES

jennison-associates-logo

Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969. Today, the firm manages over $93 billion for institutions and private clients through separately managed accounts and commingled vehicles, including mutual funds through subadvisory relationships.
#SimilarOrganizations #People #Financial #More

JENNISON ASSOCIATES

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Financial Services Venture Capital

Founded:
1969-01-01

Status:
Active

Contact:
+1 212 421 1000

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Font Awesome Mobile Non Scaleable Content Euro Microsoft Exchange Online Amazon


Similar Organizations

bioadvance-logo

BioAdvance

BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.

roche-venture-fund-logo

Roche Venture Fund

The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.


Current Advisors List

not_available_image

Timothy Knierim Board Member @ Jennison Associates
Board_member

not_available_image

Ronald Andrews Board Member @ Jennison Associates
Board_member

not_available_image

Charles Lowrey Board Member @ Jennison Associates
Board_member

not_available_image

Bernard Winograd Board Member @ Jennison Associates
Board_member

matthew-fetchko_image

Matthew Fetchko Director, Digital Marketing Strategy @ Jennison Associates
Board_member
2020-08-01

not_available_image

Deborah Wedgeworth Board Member @ Jennison Associates
Board_member

Current Employees Featured

melissa-i-mennella_image

Melissa I. Mennella
Melissa I. Mennella Assistant Supervisor @ Jennison Associates
Assistant Supervisor

not_available_image

Mark B. Baribeau
Mark B. Baribeau Managing Director, Head of Global Equity @ Jennison Associates
Managing Director, Head of Global Equity

not_available_image

Benjamin F. Bryan
Benjamin F. Bryan Managing Director and Equity Research Analyst @ Jennison Associates
Managing Director and Equity Research Analyst

not_available_image

Jason McManus
Jason McManus Managing Director and Quantitative Portfolio Manager @ Jennison Associates
Managing Director and Quantitative Portfolio Manager

not_available_image

Mehdi Asif Mahmud
Mehdi Asif Mahmud Vice Chairman, Managing Director @ Jennison Associates
Vice Chairman, Managing Director

not_available_image

L. Kenneth Moore
L. Kenneth Moore Executive Vice President @ Jennison Associates
Executive Vice President

not_available_image

Gregory Tuorto
Gregory Tuorto Managing Director and Equity Research Analyst @ Jennison Associates
Managing Director and Equity Research Analyst

not_available_image

David A. Kiefer
David A. Kiefer Managing Director and Portfolio Manager @ Jennison Associates
Managing Director and Portfolio Manager

not_available_image

John D. Saunders
John D. Saunders Equity Research Analyst @ Jennison Associates
Equity Research Analyst

not_available_image

Michael A. Del Balso
Michael A. Del Balso Director of Research for Growth Equity @ Jennison Associates
Director of Research for Growth Equity

Founder


not_available_image

Spiros Segalas

Investments List

Date Company Article Money raised
2021-06-28 Electric Last Mile Solutions Jennison Associates investment in Post-IPO Equity - Electric Last Mile Solutions 155 M USD
2021-06-23 Talkspace Jennison Associates investment in Post-IPO Equity - Talkspace 300 M USD
2021-03-17 Reunion Neuroscience Jennison Associates investment in Post-IPO Equity - Reunion Neuroscience 95 M CAD
2021-01-08 Clover Health Jennison Associates investment in Post-IPO Equity - Clover Health 400 M USD
2018-09-07 Allogene Therapeutics Jennison Associates investment in Convertible Note - Allogene Therapeutics 120 M USD
2015-08-24 Syndax Pharmaceuticals Jennison Associates investment in Series C - Syndax Pharmaceuticals 80 M USD
2015-08-18 Wave Life Sciences Jennison Associates investment in Series B - Wave Life Sciences 66 M USD
2015-08-11 Ovid Therapeutics Jennison Associates investment in Series B - Ovid Therapeutics 75 M USD
2015-08-10 Editas Medicine Jennison Associates investment in Series B - Editas Medicine 120 M USD
2015-07-23 GenSight Biologics Jennison Associates investment in Series B - GenSight Biologics 36 M USD

More informations about "Jennison Associates" on Search Engine

dfkcompany.com © 2022. All rights reserved